5
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Brain resistance to HSV-1 encephalitis in a mouse model

Pages 180-190 | Published online: 10 Jul 2009

References

  • Adler H, Beland JL, Del Pan NC, Kobzik L, Sobel RA, Rimm IJ (1999). In the absence of T cells, NK cells protect from mortality due to HSV-1 encephalitis. I Neuroimmunol 93: 208–213.
  • Anderson SL, Carton JM, Lou J, Xing L, Robin BY (1999). Interferon-induced guanylate binding protein 1 (GBP-1) mediates an antiviral effect against vesicular stomati-tis virus and encephalomyocarditis virus. Virology 256: 8–14.
  • Andjelkovic AV, Pachter JS (2000). Characterization of binding sites for chemokines MCP-1 and MIP-la on hu-man brain microvessels. I Neurochem 75: 1898–1906.
  • Balan P, Davis-Poynter N, Bell S, Atkinson H, Browne H, Minson T (1994). An analysis of the in vitro and in vivo phenotypes of mutants of HSV-1 lacking glycoproteins Gg, gE, gI or the putative gJ. I Gen Virol 75: 1245–1258.
  • Baringer JR, Pisani P (1994). Herpes simplex virus genomes in human nervous system tissue analysed by per. Ann Neurol 36: 823–829.
  • Barna M, Komatsu T, Bi Z, Reiss CS (1996). Sex difference in susceptibility to viral infection of the brain. I Neu-roimmunol 67: 31–39.
  • Barnett EM, Cassell MD, Perlman S (1993). Two neurotropic viruses, Herpes simplex virus type 1 and mouse hepati-tis virus, spread along different neuronal paths from the main olfactory bulb. Neuroscience 57: 1007–1025.
  • Bergstrom T, Conradi H, Hansson E, Liljeroth A, Vahlne A (1994). Resistance of rat central nervous system to brain-stem infection with HSV-1. Acta Neuropathol (Berlin) 87: 398–404.
  • Bi ZH, Barna M, Komatsu T, Reiss CS (1995). VSV infection in the central nervous system activates both innate and acquired immunity. I Virol 69: 6466–6472.
  • Boerman RH, Peters AC, Bloem BR, Raap AK, Van der Ploeg M (1992). Spread of herpes simplex virus to cere-brospinal fluid and the meninges in experimental mouse encephalitis. Acta Neuropathol (Berlin) 83: 300–307.
  • Boggian I, Buzzacar o E, Calistri A, Calvi P, Cavaggioni A, Mucignat-Caretta C, Pain G (2000). Asymptomatic herpes simplex virus infection of the mouse brain. J NeuroVirol 6: 303–313.
  • Campadelli-Fiume G, Cocchi F, Menotti L, Lopez M (2000). The novel receptors that mediate the entry of herpes sim-plex viruses and animal alphaherpesviruses into cells. Rev Med Virol 10: 305–319.
  • Cantin EM, Hinton DR, Chen J, Openshaw H (1995). Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus of type 1. Virol 69: 4898–4905.
  • Carr JA, Rogerson J, Mulqueen MJ, Roberts NA, Booth RFG (1997). Interleukin-12 exhibits potent antiviral activity in experimental herpesvirus infections. I Virol 71: 7799–7803.
  • Chen SH, Garber DA, Schaffer PA, Knipe DM, Coen DM (2000). Persistent elevated expression of cytokine tran-scripts in ganglia latently infected with herpes simplex virus type 1 in the absence of ganglionic replication or reactivation. Virology 278: 207–218.
  • Chou J, Kern ER, Whitley RJ, Roizman B (1990). Mapping of herpes simplex virus-1 neurovirulence to yi-34.5, a gene nonessential for growth in culture. Science 250: 1262–1266.
  • Dawson SJ, Palmer RD, Morris PJ, Latchman DS (1998). Functional role of the position 22 in the homeodomain of Brn-3 transcription factors. Neuroreport 9: 2305–2309.
  • Dix RD, McKendall RR, Baringer JR (1983). Comparative neurovirulence of Herpes Simplex Virus type 1 strains after peripheral and intracerebral inoculation in Balb/C mice. Infect Immun 40: 103–112.
  • Dobson CB, Itzhaki RF (1999). Herpes simplex type 1 and Alzheimer's disease. Neurobiol Aging 20: 457–465.
  • Doerr R, Seidenberg S (1936). Die Konkurrenz von Virusin-fektionen in Zentral Nervensystem (Phaenomen von Fl. Magrassi). Zeitsch fur Hygiene 119: 136–165.
  • Doller E, Aucker J, Weissbach A (1979). Persistence of her-pes virus type 1 in rat neurotumor cells. I Virol 29: 43–50.
  • Efstathiou S, Minson AC, Field HJ, Anderson JR, Wildy P (1986). Detection of herpes simplex virus sequences in latently infected mice and humans. I Virol 57: 446–455.
  • Enquist LW, Husak PJ, Banfield BW, Smith GA (1998). In-fection and spread of alphaherpesviruses in the nervous system. Adv Virus Res 51: 237–347.
  • Field HJ, Anderson JR, Efstathiou S (1984). A quantitative study of the effects of several nucleoside analogues on established herpes encephalitis in mice. I Gen Virol 65: 707–719.
  • Flexner S, Lewis PA (1910). Experimental epidemic po-liomyelitis in monkeys. J Exp Med 12: 227–255.
  • Fujii S, Akaike T, Maeda H (1999). Role of nitric oxide in pathogenesis of herpes simplex encephalitis in rats. Virology 256: 203–212.
  • Haarr L, Shukla D, Rodahl E, Dal CMC, Spear PG (2001). Transcription from the gene encoding the herpesvirus entry receptor nectin-1 (HveC) in nervous tissue of adult mouse. Virology 287: 301–309.
  • Halford WP, Gebhardt BM, Carr DJJ (1996). Persistent cytokine expression in trigeminal ganglion latently infected with HSV-1. J Immunol 157: 3542–3549.
  • Hatano A (1989). Intranasal infection of ICR mice with her-pes simplex virus type 1. J Otorhinolaryngol Soc Jpn 92: 579–587.
  • Hsu S-M, Raine L, Fanger H (1981). Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase tech-niques: a comparison between ABC and unlabeled antibody (PAP) procedures. I Histochem Cytochem 29: 577–580.
  • Hudson SJ, Dix RD, Streilein JW (1991). Induction of encephalitis in SJL mice by intranasal infection with HSV-1: a possible model of herpes simplex encephalitis in humans. J Infect Dis 163: 720–727.
  • Jugenblut CW (1936). On the mechanism of immunity in experimental poliomyelitis. I Infect Dis 58: 150–157.
  • Karin M, Delhase M (2000). The I-KB kinase (IKK) and NF-KB: key elements of proinflammatory signalling. Semin Immunol 12: 85–98.
  • Karpus WJ, Ransohoff RM (1998). Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease patho-genesis. J Immunol 15: 2667–2671.
  • Kastrukoff LF, Lau AS, Puterman ML (1986). Genetics of natural resistance to herpesvirus type 1 latent infection of peripheral nervous system in mice. I Gen Virol 67: 613–621.
  • Kintner RL, Brandt CR (1995). The effect of viral inoculum level and host age on disease incidence, disease severity, and mortality in a murine model of HSV-1 infection. Current Eye Res 14: 145–152.
  • Komatsu T, Bi Z, Shoshkes Reiss C (1996). Interferon y in-duced type I NO synthase activity inhibits viral replica-tion in neurons. J Neuroimmunol 68: 101–108.
  • Kriestie TM (1997). The mouse homologue of the human transcription factor Cl (host cell factor)-conservation of forms and function. I Biol Chem 272: 26749–26755.
  • Kristensson K, Lycke E, Sjöstrand J (1971). Spread of herpes simplex virus in peripheral nerves. Acta Neuropathol (Berlin) 53: 44–53.
  • Kristensson K, Nennesmo I, Persson L, Lycke E (1982). Neuron to neuron transmission of herpes simplex virus. J Neurol Sci 54: 149–156.
  • Kuypers HGJM, Ugolini G (1990). Viruses as transneuronal tracers. Trends Neurosci 13: 71–75.
  • Lachmann RH, Efstathiou S (1997). Utilization of the herpes simplex virus type 1 latency associated regulatory region to drive stable reporter gene expression in the nervous system. I Virol 71: 3197–3207.
  • Leung KN, Nash AA, Sia DY, Wildy P (1984). Clonal analy-sis of T-cell responses to herpes simplex virus: isolation, characterization and antiviral properties of an antigen-specific helper T-cell clone. Immunology 53: 623–633.
  • Levaditi C, Harvier P, Nicolau S (1922a). Etude expérimentale de l'encéphalite dite "léthargique." Ann Inst Pasteur 36(1): 3–106.
  • Levaditi C, Harvier P, Nicolau S (1922b). Etude expérimentale de l'encéphalite dite "léthargique." Ann Inst Pasteur 36(2): 8–148.
  • Levaditi C, Hornus G, Haber P (1935). Virulence de l'ultravirus herpétique administré par voie nasale et di-gestive. Méchanisme de sa neuroprobasie centripète. Ann Inst Pasteur 54: 390–420.
  • Lewandowsky G (1997). Immunohistochemical examina-tion of intracerebral T-cell recruitment and adhesion molecule induction in herpes simplex virus-infected cells. Brain Behav Immunol 11: 264–272.
  • Liedtke W, Opalka B, Zimmermann CW, Lignitz E ( 1993). Age distribution of latent herpes simplex virus and Varicella-Zoster virus genome in human nervous tissue. J Neurol Sci 116: 6–11.
  • Lopez C (1975). Genetics of natural resistance to her-pesvirus infections in mice. Nature 258: 152–153.
  • Magrassi F (1936a). Studii sull'infezione e sull'immunith da virus erpetico. Sul contenut o in virus del cervello, in rapporto a diversi ceppi di virus, a diverse vie di infezione, a diverse fasi del processo infettivo. Zeitsch Hygiene 117: 501–527.
  • Magrassi F (1936b). Studii sull'infezione e sull'immunità da virus erpetico. Rapport o tra infezione e superin-fezione di fronte ai processi immunitari: sulla possibilità di profondamente modificare il decorso e gli esiti del processo infettivo già in atto. Zeitsch Hygiene 117: 573–620.
  • Martin JR, Jenkins FJ, Henken DB (1991). Target of herpes simplex virus type 1 infection in a mouse corneal model. Acta Neuropathol (Berlin) 82: 353–363.
  • McLean JH, Shipley MT, Bernstein DJ (1989). Golgi-like transneuronal retrograde labelling with central nervous system injections of HSV-1. Brain Res Bull 22: 867–881.
  • McLean JH, Shipley MT, Bernstein DI, Corbett D (1993). Selective lesions of neural pathways following virus inoculation of the olfactory bulb. Exp Neurol 122: 209–222.
  • Morrison LA, Knipe DM (1997). Contributions of antibody and T cell subsets to protection elicited by immuniza-tion with a replication-defective mutant of HSV-1. Virol-ogy 239: 315–326.
  • Pan Y, Lloyd C, Zhou H, Dolich S, Deeds J, Gonzalo J-A, Vath J, Gosselin M, Ma J, Dussault B, Wolf E, Alperin G, Culpeper J, Gutierrez-Ramos JC, Gearing D (1997). Neu-rotactin, a membrane anchored chemokine upregulated in brain inflammation. Nature 387: 611–617.
  • Quinn JP, Dalziel RG, Nash AA (2000). Herpes virus latency in sensory ganglia-a comparison with endogenous neu-ronal gene expression. Progr Neurobiol 60: 167–179.
  • Ransohoff RM (1998). Chemokines and central nervous system inflammation. Neurotransmissions 13: 3–12.
  • Reiss CS, Plakhov IV, Komatsu T (1998). Viral replication in olfactory receptor neurons and entry into the olfactory bulb and brain. Ann NY Acad Sci 855: 751–761.
  • Sabin A (1934). Studies on the B-virus: I. The immunolog-ical identity of a virus isolated from a human case of ascending myelitis associated with visceral necrosis. Br J Exp Pathol 15: 248–268.
  • Sabin A (1938). Progression of different nasally instilled viruses along different nervous pathways in the same host. Proc Soc Exp Biol Med 38: 270–275.
  • Sanders VJ, Felisan SL, Waddell AE, Conrad AJ, Schmid P Schwarz BE, Kaufman M, Walsh GO, De Salles AA, Tourtellotte WW (1997). Presence of herpes simplex DNA in surgical tissue from human epileptic seizure foci detected by per: preliminary study. Arch Neurol 54: 954–960.
  • Slavin HB, Berry PG (1943). Studies on herpetic infection in mice. II- The pathway of invasion in the central nervous system after intranasal instillation of virus in suckling mice. J Exp Med 78: 315–321.
  • Stroop WG, Douglas C, Schaefer BA (1989). Neurovirulence of two clonally related herpes simplex virus type 1 in a rabbit seizure model. J Neuropathol Exp Neurol 48: 171–183.
  • Su YH, Moxley M, Kejarival R, Mehta A, Fraser NW, Block TM (2000). The herpes simplex virus type 1 genome in quiescently infected NGF differentiated PC12 cells can-not be stimulated by HSV superinfection. I NeuroVirol 6: 341–349.
  • Thompson KA, Blessing WW, Wessenlingh SL (2000). Her-pesvirus replication and dissemination is not increased by corticosteroid treatment in a rat model of focal her-pesvirus encephalitis. J NeuroVirol 6: 25–32.
  • Tomlinson H, Esiri MM (1983). Herpes simplex encephali-tis. Immunohistological demonstration of spread of virus via olfactory pathways in mice. I Neurol Sci 60: 473–484.
  • Valyi-Nagy T, Olson SJ, Valyi-Nagy K, Montine TJ, Dermody TS (2000). Herpes simplex virus type 1 latency in the murine nervous system is associated with oxida-tive damage to neurons. Virology 278: 309–321.
  • Veratti E, Sala G (1923). Sulla infezione erpetica nel coniglio. Boll della Soc Med Chir di Pavia 36: 266–306.
  • Warren TG, Hippenmeier PJ, Meyer DM, Reitz BA, Rowold E Jr, Carron CP (1994). High-level expression of biologically active, solubile forms of ICAM-1 in a novel mammalian-cell expression system. Protein Expr Purif 5: 498–508.
  • Weinstein DL, Walker DJ, Akyiama H, McGreer PL (1990). Herpes simplex virus type 1 infection of the central ner-vous system induces MHC antigen expression in rat mi-croglia. I Neurosci Res 26: 55–65.
  • Whitley BJ (1996). Herpes simplex virus. In: Fields Virology. Fields BN, Knipe DM, Howley PM (eds). Lippincott-Raven: Philadelphia, pp 2297–2296.
  • Wolf LW, LaRegina MC, Tolbert DL (1996). A behavioral study of the development of hereditary cerebellar ataxia in the shaker rat mutant. Behav Brain Res 75: 69–81.
  • Zhou G, Galvan V, Campanelli-Fiume G, Roizman B (2000). Glycoprotein D or J delivered in trans blocks apoptosis in SK-N-SH cells induced by a HSV-1 mutant lacking intact genes expressing both glycoproteins. I Virol 74: 11782–11791.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.